81 / 89
81
95.
Baron M, Hudson M, Steele R; Canadian
Scleroderma Research Group. Malnutrition is
common in systemic sclerosis: results from the
Canadian scleroderma research group database.
J Rheumatol 2009;36:2737-43.
96.
Cliff IS, Herber R, Demis DJ. Control of
malabsorption in scleroderma. J Invest
Dermatol 1966;47:475-83.
97.
Alpert LI, Warner RR. Systemic sclerosis: case
presenting
with
tetracycline-responsive
malabsorption
syndrome.
Am
J
Med
1968;45:468-73.
98.
Brown M, Teubner A, Shaffer J, Herrick AL.
Home parenteral nutrition—an effective and
safe long-term therapy for systemic sclerosis-
related
intestinal
failure.
Rheumatology
(Oxford) 2008;47:176-9.
99.
Parodi A, Sessarego M, Greco A, Bazzica M,
Filaci G, Setti M, et al. Small intestinal bacterial
overgrowth in patients suffering from
scleroderma: clinical effectiveness of its
eradication. Am J Gastroenterol 2008;103:1257-
62.
100.
Schnabel A, Reuter M, Gross WL. Intravenous
pulse cyclophosphamide in the treatment of
interstitial lung disease due to collagen
vascular
diseases.
Arthritis
Rheum
1998;41:1215-20.
101.
Yiannopoulos G, Pastromas V, Antonopoulos
I, Katsiberis G, Kalliolias G, Liossis SN, et al.
Combination of intravenous pulses of